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Summary
Background: The relationship between malaria and obesity are largely unknown. This is partly
due to the fact that malaria occurs mainly in tropical areas where, until recently, obesity was not
prevalent. It now appears, however, that obesity is emerging as a problem in developing countries.
To investigate the possible role of obesity on the host-parasite response to malarial infection, this
study applied a murine model, which uses the existence of genetically well characterized obese
mice.
Methods: The receptivity of obese homozygous ob/ob mice was compared to the receptivity of
control heterozygous ob/+ lean mice after a single injection of Plasmodium berghei ANKA
sporozoites. Both parasitaemia and mortality in response to infection were recorded.
Results: The control mice developed the expected rapid neurological syndromes associated with
the ANKA strain, leading to death after six days, in absence of high parasitaemia. The obese mice,
on the other hand, did not develop cerebral malaria and responded with increasing parasitaemia,
which produced severe anemia leading to death 18–25 days after injection.
Conclusion: The observed major differences in outward symptoms for malarial infection in obese
versus control mice indicate a link between obesity and resistance to the infection which could be
addressed by malariologists studying human malaria.
Introduction
Obesity, mainly characterized by an excess of adipose tis-
sue, is associated with high risks of developing several
pathologies that have disastrous consequences. This
health condition is of paramount importance for public
health in developed countries. For example, in the USA
more than half of the population is considered to be
obese according to the WHO criteria. Obesity has also
been identified as an emerging condition in developing
countries, especially in towns of tropical areas [1,2].
Crude NCBI-PubMed searches with "obesity" and
"malaria" yielded 107,545 and 46,653 references, respec-
tively. However, association of the two terms produced
only 17 entries, two of which partially addressed the issue
[3,4], indicating that the two communities of researchers
occupy distinct scientific niches that do not overlap. A
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limited survey amongst fellow malariologists also
revealed the lack of bridges between the two disciplines.
Finally, a search in the French database of all recorded
malaria cases (about 45,000) was eloquent: the body-
weight of the studied patients was simply not recorded.
Several studies have been performed on malaria and mal-
nutrition in humans [5-7]. They strongly suggest that
malaria is the major contributor to growth retardation in
children living in endemic areas. Evidence from observa-
tional cohorts indicated that malnutrition decreases the
susceptibility to malaria, and that this may be due to an
interaction between the parasite and the host immune
system [8]. At the same time, it can also worsen the prog-
nosis of malaria [9]. However, the point at which malnu-
trition ceases to be protective and becomes an adverse
prognosticator is not clear [10]. Experiments with mice
demonstrate that nutritional status interferes with the
expression of malarial disease. Lean mice fed on a normal
diet (25% protein) suffered severe parasitaemia and died
within two weeks when infected with a lethal strain of
Plasmodium yoelii, whereas mice fed on low-protein diet
survived without apparent parasitaemia. This response
has been related to an enhanced innate immunity in mice
fed on low-protein diet [11]. In another study, P. berghei
malaria sporozoites were less infective in knock out LDLR-
/- mice (low density lipoprotein receptors) maintained on
a high fat diet, as compared to littermates maintained on
a normal diet [12]. While some studies suggest a link
between nutritional status (malnutrition) and the evolu-
tion of malaria infections, little is known about the rela-
tionship of obesity vis-à-vis the prevalence or evolution of
malarial infections in human [13]. Considering the
increasing world concern about obesity, on the one hand,
and malaria on the other, any relationship between both
clinical statuses would be of great significance.
This study investigated the possibility of such a relation-
ship, using the murine model ob/ob, which provides valu-
able tools for studying obesity. The obese ob/ob  mice
(C57BL/6 background) have developed a spontaneous
recessive and nonsense punctual mutation in the leptin
gene which, in the mutant ob/ob homozygote, encodes for
a truncated non-functional protein, resulting in the
absence of retro-control on hunger. These leptin-deficient
mice exhibit irrepressive feeding behaviour and develop a
patent obesity [14]. Leptin, a hormone mainly produced
by adipocytes, is a central mediator of the neuroendocrine
pathways involved in the control of food intake, basal
metabolism and reproductive function. As a consequence,
ob/ob mice exhibit a hyperlipidemia caused by an increase
in hepatic triglyceride synthesis and secretion [15]. The
obese mice also develop hyperglycaemia and type 2 dia-
betes, which occurs as a consequence of obesity rather
than a primary effect of leptin. Recent evidence also indi-
cates that leptin acts as a proinflammatory cytokine [16].
A literature search indicates that obese mice have not been
experimentally infected by malaria parasites previously.
Obesity could play a protective, neutral or permissive role
in the evolution of malarial infections and subsequent
patho-physiological manifestations. However, many fac-
tors can interfere. Here, using the ANKA strain of P. berghei
which induces cerebral malaria in C57BL/6 mice, it has
been shown that the outcome of malaria infection differs
dramatically between obese and control lean mice. Con-
trary to the control mice, the obese mice did not develop
cerebral malaria.
Materials and methods
Nine eleven week-old C57BL/6 homozygous ob/ob male
mice were obtained from a rearing centre (R. Janvier,
53940 Le Genest-Saint-Isle, France). The controls were
heterozygote ob/+ mice from the same rearing centre and
of the same sex and age. The mice were infected by intra-
venous inoculation of either 50,000 or 100,000 P. berghei
(clone 15cy1 of the ANKA strain) sporozoites isolated
from laboratory infected Anopheles stephensi. The mean
weights of the obese and control mice at day 0 (the day of
inoculation) were 47.1 g and 25.4 g, respectively. Parasi-
taemia was monitored daily by microscopic examination
of Giemsa stained-thin blood smears. Parasite counts
were performed at 1,000× magnification on smear regions
with an estimation of 1,000 erythrocytes per field, on 20–
100 microscopic fields for parasitaemias ≤ 3%. For higher
parasitaemias, usually associated with anaemia, examina-
tions were performed on 4–10 fields with parallel counts
of parasitized and unparasitized erythrocytes. In the
absence of observed parasites, thin smears were examined
over 30 minutes. Parasite counts were expressed as per-
centage of erythrocytes. Two independent experimental
series have been performed; the results are in perfect
agreement and are, therefore, presented as a single set,
except in Table 1.
Results
All injected mice (14 obese ob/ob and 14 control ob/+)
developed infection with parasites observed in the blood
as early as day 3 post infection (PI). Among the control
mice, 8 out of 14 died from cerebral malaria at day 6 PI
without precursory clinical signs (Fig. 1-A) and with para-
site blood densities of around 3%. Within this control
group, the mice had similar parasitaemias at any day
whatever the outcome of their symptoms; at day 6, mean
parasitaemia was 2.73% in mice that survived (6/14) and
3.18% in mice that died a few hours later (8/14), P = 0.44
by the Man-Whitney U test. The surviving mice ultimately
died after day 19 from severe anaemia resulting from highMalaria Journal 2008, 7:81 http://www.malariajournal.com/content/7/1/81
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parasite densities reaching up to 40% (Fig. 1-B). At day 18
PI, their mean body weight was 20.2 g.
In contrast, the obese mice did not present any clinical
sign of cerebral malaria (behavioral changes or coma).
They died from severe anaemia between days 18 and 25 PI
(those surviving at day 25 were in the final phase and sac-
rificed). Cox proportional hazard indicated a P-value of
2.8 × 10-5 and a death risk factor, at any moment, 7.34
times lower for obese mice. The parasitaemia was higher
in the obese mice than in the control mice from day 3 to
day 8 PI (Fig. 1-B), but the daily differences were never sig-
nificant (0.98 > P > 0.07 by the Mann-Whitney U test),
except at day 3 (0.017 parasitized erythrocytes per 100
erythrocytes in the control mice vs. 0.039 in the obese
mice; P = 0.032). At day 18 PI, the mean body weight of
the surviving ob/ob mice was 45.8 g.
The amount of injected sporozoites per mouse (50,000 or
100,000) had only transitory consequences on parasitae-
mias that were detectable only at days 3 and 4 PI (Table
1), indicating that doubling the sporozoite dose propor-
tionally to the obese weight does not affect the observed
responses in terms of mortality.
Discussion
This study appears to provide the first indication that lep-
tin-deficient ob/ob obese mice are permissive for the infec-
tion by Plasmodium berghei ANKA and resistant to cerebral
malaria. This resistance cannot be explained solely by the
larger size of these mice, as weight-adjusted doses of spo-
rozoites were given. The protection of the obese mice with
respect to cerebral malaria was unexpected, since they
share the same C57BL/6 genetic background as the lean
mice which are well known to be susceptible to cerebral
malaria, usually dying from typical neurological symp-
toms between days 6–9 after infection [17]. The suscepti-
bility to cerebral malaria of this strain is confirmed by
observations with the control lean heterozygote ob/+
mice.
Cerebral malaria induced by P. berghei ANKA is known to
be under genetic regulation, but the mechanisms leading
to protection versus death from cerebral malaria are not
yet fully understood in normal non-obese mice [18].
Using mice of different genetic backgrounds which are
either cerebral malaria (CM) sensitive or CM resistant,
and comparing gene expression profiling, Delahaye et al
[19,20] identified a large set of genes that discriminates
between CM sensitive and resistant mice, including genes
involved in regulating immune responses. Not surpris-
ingly, the obese phenotype affects the expression of a large
panel of genes, mainly involved in metabolic pathways
possibly inducing resistance to CM [21,22]. The leptin
gene mutation in ob/ob is associated with observed protec-
tion against CM but, considering the complex and pleio-
trophic effect of the leptin mutation in ob/ob mice, it is
hard to speculate whether the unique mutation of the lep-
tin  gene would be totally responsible, per se, for the
observed CM resistance phenotype in obese mice.
Several lines of evidences can be related to possible mech-
anisms involved in this protection. Among them are many
related to the nutritional status and plasmatic lipid com-
position involved in immune responses. So the deep
modifications of the lipid metabolism in ob/ob mice can
have implications. Obese mice exhibit a hyperlipidemia
caused by an increase in hepatic triglyceride synthesis and
secretion [15]. Interestingly, it has been demonstrated
that injection of fatty acids during the first three days after
infection protected C57BL/6 lean mice infected by P.
berghei ANKA from cerebral symptoms [23]. Regulation of
glycemia is also affected in obese mice, resulting in hyper-
glycemia that may compensate the hypoglycemia com-
monly observed in severe or complicated malaria attacks.
Elased  et al [24] observed that infection with P. yoelii
induces hypoglycemia in normal mice and normalizes the
hyperglycemia in moderately diabetic mice. In contrast,
blood glucose concentrations significantly rose in mice
exhibiting neurological symptoms during infection with
P. berghei ANKA [25].
Table 1: Parasitaemias of Plasmodium berghei ANKA-infected C57BL/6 mice, as % of parasitized red blood cell.
Number of sporozoites per mouse Day of infection 2 3 4 5 6 7 8 10 14 19
C o n t r o l 5 0 , 0 0 0 N u m b e r  o f  m i c e 9 9 9 9922222
ob/+ Mean parasitaemia 0.000 0.011 0.221 1.61 3.01 2.83 3.42 7.37 32.4 39.9
Standard deviation -- 0.006 0.109 0.29 1.07 1.38 0.44 3.09 21.2 7.8
O b e s e 5 0 , 0 0 0 N u m b e r  o f  m i c e 5 5 5 5555555
ob/ob Mean parasitaemia 0.000 0.014 0.110 1.57 3.34 3.83 4.81 4.83 11.2 18.3
Standard deviation -- 0.009 0.113 0.40 0.40 0.94 1.35 1.16 6.07 5.78
Obese 100,000 Number of mice 4 4 4 4 4 4 4 4 4 4
ob/ob Mean parasitaemia 0.000 0.027 0.321 1.96 3.94 4.61 3.81 4.16 10.8 23.9
Standard deviation -- 0.025 0.155 0.51 0.96 0.85 1.35 0.28 6.12 5.11
Results of the first experimental series of infection, comparing the doses of injected sporozoites.Malaria Journal 2008, 7:81 http://www.malariajournal.com/content/7/1/81
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On the other hand, ob/ob mice are leptin-deficient, and
this could be one of the key factors involved in the
observed resistance. Indeed, a progressive increase of lep-
tin concentration was observed in P. berghei (Swiss Tropi-
cal Institute strain)-infected C57BL/6 lean mice, and the
level of leptin increased five times when compared with
non-infected control mice, six days after infection [26].
Leptin is involved in protective mechanisms, allowing an
organism to deal with the potentially auto-aggressive
effects of its immune system [27]. In other experiments,
injections of leptin were claimed to protect against TNF
toxicity in ob/ob but not in +/+ mice [28]; therefore, it is
possible that leptin protects against cerebral malaria by
damping down TNF-induced pathology. Similar in struc-
ture to interleukin 2, an important T-cell growth factor,
leptin modifies proinflammatory immune responses and
may provide a key link between nutritional deficiency and
immune dysfunction. Obese ob/ob  mice have impaired
cell-mediated immunity and a propensity to develop Th2
rather than Th1 immune responses [29]. A decrease in the
Th1: Th2 ratio could be related to the observed resistance
in obese mice because cerebral malaria due to P. berghei
ANKA involves the Th1 cytokines TNF-α and INF-γ in the
regulatory cascade controlling inflammatory responses
after malarial infections [30].
Leptin can also regulate aspects of hemopoiesis, inducing
proliferation, differentiation and functional activation of
hemopoietic cells, but it has a weak impact on the bone-
marrow nucleated erythroid cells [31]. In other words, the
severe anaemia observed in infected obese mice is a direct
consequence of erythrocyte destruction by parasite prolif-
eration, rather than leptin deficiency. Similar anaemia
was observed in the few control mice that did not develop
cerebral malaria.
While this study addressed the outcome of malaria in ob/
ob  mice, which are non-diabetic until the fourth week
[32], it questions what would be the response of db/db dia-
betic mice, which also present obese phenotype. Indeed,
drug-induced diabetic mice were shown to better control
parasitaemia with enhanced phagocytic activity compared
to normal mice [33]. Apparent normalization of blood
glucose concentration was also observed in a diabetic
patient suffering from P. falciparum malaria [34]. On the
contrary, in mice exhibiting neurological symptoms dur-
ing infection with P. berghei ANKA, blood glucose concen-
trations were significantly raised in line with TNF levels
[25].
Beyond the malaria symptoms previously discussed, par-
asite density is worth considering. The data from this
study showing higher parasitaemia in ob/ob mice during
days 3–8 after infection are in agreement with what has
been observed in obese fa/fa Zucker rats infected by P. yoe-
lii yoelli presenting higher parasitaemias than hetero-
zygous control rats. The higher and significant
parasitaemia in ob/ob mice at day 3 questions a possible
increased productivity of hepatic merozoites, as observed
in single gene mutated Zucker rats [35].
It is noteworthy that mutations affecting leptin exist in
humans, but with inconstant phenotypic manifestations
in terms of obesity [36]. Although experimental cerebral
malaria models cannot reproduce all the features of
human cerebral malaria, several observations in mice
have been extended and confirmed in the human disease
[37]. They include immunological responses, blood-bar-
rier function, histopathological features and expression of
molecules in the brain and the retina, biochemical
changes in the brain and behavioral changes. Events
resulting in the development of human cerebral malaria
complications are clearly multi-factorial, encompassing a
dynamic interaction between sequestration, inflamma-
A- Survival curves for obese ob/ob mice and control ob/+  mice after infection by Plasmodium berghei ANKA at day 0; B-  Parasitaemias with standard deviations, as % of parasitized  red blood cell Figure 1
A- Survival curves for obese ob/ob mice and control 
ob/+ mice after infection by Plasmodium berghei 
ANKA at day 0; B- Parasitaemias with standard devi-
ations, as % of parasitized red blood cell. (Note the Log 
scale for vertical axis.) Continuous line, ob/+; broken line, ob/
ob.Malaria Journal 2008, 7:81 http://www.malariajournal.com/content/7/1/81
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tion and homeostasis, in a complex syndrome leading to
microcirculatory dysfunction [30,38].
Conclusion
Control heterozygous mice infected with P. bergei ANKA
developed rapid neurological syndromes leading to
death, without high parasitaemia. By contrast, obese ob/ob
mice did not develop cerebral malaria and presented an
increasing parasitaemia resulting in severe anaemia.
Although it is not possible to make inferences from mice
to humans from these observations, the study highlights
the need to recognize and address a possible link between
obesity and its effect on the response to malarial infection
in human populations.
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